BioSphings AG - novel therapeutic approaches for the treatment of cancer, autoimmune diseases and viral infections

Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - BioSphings AG. Innovating viral phospholipase inhibitor to prevent expression of Herpes specific genes, and intracellular viral antigens, and drug inducing death of tumor cells and autoreactive immune cells, in multiple sclerosis, rheumatism, and Crohn's disease.